BTG2 was also identified as a differentiation and anti-apoptotic factor in neurogenesis [37]. parental HeLa cells by detecting their radioresistant characteristics, respectively. Compared to HeLa cells, the expression of 24 genes was significantly altered by at least 2-fold in HeLaNR cells. Of these, 19 genes were up-regulated and 5 down-regulated. In HeLaXR cells, 41 genes were significantly altered by at least 2-fold; 38 genes were up-regulated and 3 down-regulated. == Conclusions == Chronic exposure of cells to ionizing radiation induces adaptive responses that enhance tolerance of ionizing radiation and allow investigations of cellular radioresistance mechanisms. The insights gained into the molecular mechanisms activated by these “radioresistance” genes will lead to new therapeutic targets for cervical malignancy. == Background == Cervical malignancy is a worldwide disease, with a high incidence and mortality [1] especially in developing countries. Approximately 500, 000 LY2119620 cases of cervical malignancy are diagnosed annually, with mortality around 40% [2]. Radiotherapy is particularly effective for patients with cervical cancers at an advanced stage or Rabbit polyclonal to HSP27.HSP27 is a small heat shock protein that is regulated both transcriptionally and posttranslationally. that cannot be cured surgically. Low LET radiation (e.g., gamma rays, X-rays) is generally used to treat cervical cancers, but its ability to remedy local disease decreases with increasing tumor size, because the doses required to treat large tumors exceed the toxicity limits of normal tissues [3]. High LET radiation such as neutron rays is usually associated with a low rate of repair of potentially lethal DNA damage, allowing better local control of the tumor and thus less chance of recurrence. Theoretically, high LET radiation has several advantages over low LET radiation: (a) more damage to hypoxic cells; (b) decreased repair of IR-induced damage; and (c) effectiveness at all stages of the cell cycle [4]. The 5-12 months overall survival rate of cervical malignancy patients who received252Cf neutron ray radiotherapy was reported to be 76.8% at stage II and 70.9% at stage III [5]. Another study showed that this 10-year survival rate was better in cervical malignancy patients treated with252Cf neutron rays than in those treated with gamma radiation (69.1% vs. 50.9%, respectively) [6]. However, despite the improved efficacy of252Cf neutron rays in the therapy of cervical malignancy, tumors recurrence has been reported. A substantial body of evidence has implicated DNA as the primary target in lethal ionizing radiation (IR) [7]. In many human tumor lines, radiosensitivity correlated with DNA damage induction and repair [8-10]. The activity of the DNA damage repair pathway is one of the most important factors leading to radioresistance in tumors, including cervical malignancy. This pathway as well as others contributing to radioresistance in cervical malignancy can be analyzed by cDNA microarray analyses of gene expression. Thus, in the present work, long-term252Cf neutron ray and X-ray irradiation of HeLa cells was used to generate two radioresistant cell sub-lines, HeLaNR and HeLaXR, which provided a model system for studying the radioresistance mechanisms of cervical malignancy cells. Insights into the mechanisms of resistance will contribute to improvements in malignancy treatment. == Methods == == Cell lines == The HeLa cell collection was obtained from the American Type Culture Collection and cultured in DMEM-high glucose medium (GIBCO) supplemented with 10% newborn calf serum (Biochrom AG), penicillin (100 U/ml), and streptomycin (100 g/ml) (Sigma). Cells were incubated in 5% CO2at 37C and passaged 2-3 occasions weekly.252Cf neutron ray (HeLaNR) and X-ray (HeLaXR) resistant sub-lines were generated by continuous sublethal irradiation for 8 months with252Cf neutron and X-rays, respectively, with a total dose of 75 Gy each. The parental cell collection LY2119620 (HeLa) and the radioresistant sub-lines (HeLaNR and HeLaXR) were maintained under the same conditions. To control for acute effects of IR, the radioresistant sub-lines were cultured for over 2 months after the last irradiation before being used in the analyses. == Irradiation == For X-ray treatment, cells were cultured in 25-cm2flasks until they reached 75% confluence and then irradiated at 200 cGy/min, at room temperature, with a Precise linear accelerator (Elekta) operating at 8 MV. For252Cf neutron ray treatment, trypsinized cells were harvested in a tube and then irradiated with LY2119620 a neutron emission rate of 2.3 106/s/g, a emission rate of 1 1.3 107/s/g, and a dose rate in air flow of 23.4 mSv/hmg at.